KPTI Stock Analysis: Buy, Sell, or Hold?
KPTI - Karyopharm Therapeutics Inc.
$2.12
0.17 (8.72%)
▲
5d:
+10.42%
30d:
-79.22%
90d:
-76.05%
WAIT
LOW Confidence
Analysis Updated: Aug 7, 2026 12:00 AM ET
Earnings: Aug 10, 2026
1d
Get Alerted When KPTI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: KPTI shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: KPTI shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: KPTI is currently trading at $2.12, which is considered oversold relative to its 30-day fair value range of $4.39 to $10.45.
Technical Outlook: Technically, KPTI is showing sideways momentum. Immediate support is located at $1.80, while resistance sits at $7.84. The stock is showing strong short-term momentum, up 8.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.40 (+201.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, KPTI is showing sideways momentum. Immediate support is located at $1.80, while resistance sits at $7.84. The stock is showing strong short-term momentum, up 8.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.40 (+201.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.39 -
$10.45
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+8.7%)
- BULLISH: Trading 201.9% below Wall St target ($6.40)
- WARNING: Composite score 51/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$4.39 -
$10.45
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.80
Resistance Level
$7.84
Current Trend
Sideways
Technical data as of
Aug 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.66
Wall Street Target
$6.40
(+201.9%)
Revenue Growth (YoY)
16.8%
Profit Margin
-129.0%
Share & Embed Analysis
Last updated: August 08, 2026 5:26 AM ET
Data refreshes hourly during market hours. Next update: 6:26 AM
Data refreshes hourly during market hours. Next update: 6:26 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KPTI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Reshma Rangwala
SELL
449 shares
2026-04-21
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$89 | 58 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 56 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 51 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 57 HOLD |
